Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Akron Bio logo — Powering the future of medicine

Akron Bio

Powering the future of medicine

Founded 2006 United States Boca Raton, United States 113 employees Biotechnology, Health Care +1

General Information

Company Name Akron Bio
Founded Year 2006
Location United States Boca Raton, United States
Employees 113
Industries Biotechnology, Health Care, Manufacturing
Social

BounceWatch is an independent company data service, not affiliated with Akron Bio. To contact Akron Bio, visit akronbiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Akron Bio compare?

A PDF of Akron Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Akron Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Akron Bio

Akron Bio is a biotechnology, health care, and manufacturing company founded in 2006 in the United States. The company is dedicated to powering the future of medicine by providing GMP-compliant materials and services that enable innovators to develop and commercialize advanced therapies. Since its inception, Akron has been a key player in the biotechnology and healthcare industries. The company specializes in manufacturing custom plasmids and endonucleases to support viral vector and gene editing technologies, in addition to offering a line of GMP quality cytokines, growth factors, blood-derived products, and custom media. Notably, Akron's newly opened 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards, ensuring the production of high-quality products adhering to regulatory requirements. Akron positions itself as a strategic partner for advanced therapy developers, providing the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through to commercialization. As of the latest available information, Akron Bio has not disclosed its last investment details or the involved investors. This indicates that the company may be open to potential investment opportunities or funding rounds in the future.

Business keywords: regenerative medicine, GMP compliance, advanced therapies, cell and gene therapy, manufacturing facility, clinical trial support, FDA compliance, custom plasmids, gene editing technologies, tissue engineering, cryopreservation media, stem cell products, recombinant proteins, commercialization support

No funding data available for Akron Bio yet.

Akron Bio Alternatives & Competitors

View All Alternatives
Akron Bio vs
China Regenerative Medicine International
China Regenerative Medicine International Hong Kong S.a.r.

Pioneering the future of regenerative medicine with advanced gene and stem cell products.

16 employees
Biotechnology, Manufacturing
Akron Bio vs
RoslinCT
RoslinCT United Kingdom

Your Advanced Cell & Gene Therapy CDMO Partner

Private Equity
350 employees
Biotechnology, Manufacturing
Akron Bio vs
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. United States

Transforming medicine through engineered cellular therapies that restore, regenerate, and repair tis...

Grant
21 employees
Biotechnology, Health Care
View all alternatives

FAQ About Akron Bio

Powering the future of medicine
Akron Bio was founded in 2006.
Akron Bio is headquartered in Boca Raton, United States.
Akron Bio operates in Biotechnology, Health Care and Manufacturing. Its work centres on regenerative medicine, GMP compliance, advanced therapies and cell and gene therapy.
Akron Bio has approximately 113 employees.
Top alternatives and competitors to Akron Bio include China Regenerative Medicine International, RoslinCT, Angiocrine Bioscience, Inc., Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA, Stembio Cell and Tissue Technologies Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Akron Bio and China Regenerative Medicine International are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Akron Bio, https://bouncewatch.com/company/akron-bio, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes